Cargando…
Tumor Necrosis Factor Inhibition and Parkinson Disease: A Mendelian Randomization Study
OBJECTIVE: To evaluate the effects of long-term tumor necrosis factor (TNF) inhibition on the risk and age at onset of Parkinson disease (PD), we performed a 2-sample Mendelian randomization study using genome-wide association studies (GWAS) summary statistics. METHODS: Genetic variants in the vicin...
Autores principales: | Kang, Xiaoying, Ploner, Alexander, Pedersen, Nancy L., Bandres-Ciga, Sara, Noyce, Alastair J., Wirdefeldt, Karin, Williams, Dylan M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8032365/ https://www.ncbi.nlm.nih.gov/pubmed/33608417 http://dx.doi.org/10.1212/WNL.0000000000011630 |
Ejemplares similares
-
In vivo distribution of α-synuclein in multiple tissues and biofluids in Parkinson disease
por: Chahine, Lana M., et al.
Publicado: (2020) -
White Matter Hyperintensities Are Not Related to Symptomatology or Cognitive Functioning in Service Members with a Remote History of Traumatic Brain Injury
por: Lippa, Sara M., et al.
Publicado: (2021) -
INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease
por: Meyer, Pierre-François, et al.
Publicado: (2019) -
Randomized controlled trial of N-acetylcysteine therapy for RYR1-related myopathies
por: Todd, Joshua J., et al.
Publicado: (2020) -
Natalizumab in acute ischemic stroke (ACTION II): A randomized, placebo-controlled trial
por: Elkind, Mitchell S.V., et al.
Publicado: (2020)